리포산 유도체를 함유하는 약제학적 제형
- 专利权人:
- 发明人:
- 쇼르, 로버트, 지.아이.,바신, 라진더,로드리게즈, 로버트, 제이.
- 申请号：
- KR1020097023900
- 公开号：
- KR1015397850000B1
- 申请日:
- 2008.04.17
- 申请国别(地区):
- KR
- 年份:
- 2015
- 代理人:
- 摘要：
- lipoic acid derivatives containing a pharmaceutical formulation is prepared.lipoic acid derivatives, carcinoma, sarcoma, myeloma, lymphoma, leukemia, bis-benzyl benzoate Lippo , triethanolamine리포산 유도체를 함유하는 약제학적 제형이 제조된다.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one lactic acid salts
- CRYSTALLINE FORMS AND TWO SOLVATED FORMS OF 4-AMINO-5-FLUORO-3-[5-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE LACTIC ACID SALTS
- КОМБИНИРОВАННАЯ ТЕРАПИЯ ДЕКСАМЕТАЗОНОМ
- DOSED MEDICINAL FORMS 3- (6- (1- (2,2-DIFLUORBENZO [d] [1,3] DIOXOL-5-IL) CYCLOPROPANCARBOXAMIDO) -3-METHYLPYRIDIN-2-IL) BENZOIC ACID
- CRYSTALLINE FORMS OF N-(4-((3-(2-AMINO-4-PYRIMIDINYL) - 2-PYRIDINYL)OXY)PHENYL)-4-(4-METHYL-2-THIENYL)-1 -PHTHALAZINAMINE PHARMACEUTICALLY ACCEPTABLE SALTS AND USES THEREOF
